NTRK2 and neoplasm: Research has found that the upregulated activation signals of BDNF/TrkB in tumor cells stimulate a series of downstream pathways, including PI3K/AKT, Ras–Raf–MEK–ERK, PLC‐γ, as well as the transactivation of epidermal growth factor receptor.